The role of teprotumumab in chronic, clinically active thyroid eye disease
CY Yu, BA Simmons, CM Pham, EM Shriver - Eye, 2022 - nature.com
Thyroid eye disease (TED) is a chronic inflammatory condition that can lead to permanent
disfigurement, disability, and vision loss. It is traditionally believed that TED is a self-limited …
disfigurement, disability, and vision loss. It is traditionally believed that TED is a self-limited …
[引用][C] The role of teprotumumab in chronic, clinically active thyroid eye disease
YY Caroline, BA Simmons, CM Pham… - Eye (London …, 2022 - pubmed.ncbi.nlm.nih.gov
The role of teprotumumab in chronic, clinically active thyroid eye disease The role of
teprotumumab in chronic, clinically active thyroid eye disease Eye (Lond). 2022 Jul;36(7):1500-1501 …
teprotumumab in chronic, clinically active thyroid eye disease Eye (Lond). 2022 Jul;36(7):1500-1501 …
The role of teprotumumab in chronic, clinically active thyroid eye disease
YY Caroline, BA Simmons, CM Pham, EM Shriver - Eye, 2022 - ncbi.nlm.nih.gov
Thyroid eye disease (TED) is a chronic inflammatory condition that can lead to permanent
disfigurement, disability, and vision loss. It is traditionally believed that TED is a self-limited …
disfigurement, disability, and vision loss. It is traditionally believed that TED is a self-limited …
The role of teprotumumab in chronic, clinically active thyroid eye disease.
CY Yu, BA Simmons, CM Pham… - Eye (London, England …, 2022 - europepmc.org
Thyroid eye disease (TED) is a chronic inflammatory condition that can lead to permanent
disfigurement, disability, and vision loss. It is traditionally believed that TED is a self-limited …
disfigurement, disability, and vision loss. It is traditionally believed that TED is a self-limited …
[引用][C] The role of teprotumumab in chronic, clinically active thyroid eye disease
YY Caroline, BA Simmons, CM Pham, EM Shriver - Eye (London) - iro.uiowa.edu